Answers are grounded in this paper and cite their sources.
The disposition of infliximab in patients with moderately to severely active ulcerative colitis, unlike in rheumatoid arthritis, was not affected by coadministration of immunomodulators and corticosteroids but was related to formation of antibodies to infliximab and, notably, to serum albumin levels.
No takes yet. Share an insight, caveat, or question.
Fasanmade et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: